Mayo Clinic Laboratory and pathology research roundup: August 22

By Samantha Rossi • August 22, 2023

Share this:

The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.

Featured Abstract

Association of plasma biomarkers of Alzheimer Disease with cognition and medical comorbidities in a biracial cohort.

Recent advances in blood-based biomarkers offer the potential to revolutionize diagnosis and management of Alzheimer's disease (AD), but additional research in diverse populations is critical. We assessed the profiles of blood-based AD biomarkers and their relationships to cognition and common medical comorbidities in a biracial cohort.

Read more.

Published to PubMed This Week

• Emerging concepts in dermatopathology: A special issue of neoplastic, inflammatory, and special-site dermatopathology, and important practice considerations.
  Human Pathology
• Meningioma: A biography - tumor forever tied to the origins and "Soul of Neurosurgery".
  World Neurosurgery
• Confirmation of insertion, deletion, and deletion-insertion variants detected by next-generation sequencing.
  Clinical Chemistry
• Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events.
  Blood Cancer Journal
• Association of adverse effects with high serum posaconazole concentrations.
  Medical Mycology
• "Autoimmune HIT" antibodies in diagnostic samples are a potential artifact and not associated with more severe outcomes.
  Blood Advances
• Mortality after nocardiosis: Risk factors and evaluation of disseminated infection.
  Open Forum Infectious Diseases
• Clinicopathologic characterization of hepatocellular adenomas in men: a multicenter experience.
  Human Pathology
• Comparison of two assays to diagnose herpes simplex virus in patients with central nervous system infections.
  Journal of Clinical Virology
• Eculizumab for the treatment of glycine receptor antibody associated stiff-person syndrome.
  Journal of Neurology

Samantha Rossi

Samantha Rossi is a Digital Marketing Manager at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Samantha has worked at Mayo Clinic since 2019.